You are here:

botulinum neurotoxin type A (Xeomin)

Advice

Following a full submission

clostridium botulinum neurotoxin type A (Xeomin) is accepted for use within NHS Scotland for the symptomatic management of blepharospasm and cervical dystonia of a predominantly rotational form (spasmodic torticollis) in adults.

For both indications, a similar improvement in symptoms has been shown compared to another clostridium botulinum neurotoxin type A.

Drug Details

Drug Name: botulinum neurotoxin type A (Xeomin)
SMC Drug ID: 464/08
Manufacturer: Merz Pharma UK Ltd
Indication: symptomatic management of blepharospasm and cervical dystonia of a predominantly rotational form (spasmodic torticollis) in adults
BNF Category:
Sub Category: 4.10 Drugs used in substance dependance
Submission Type: Full submission
Status: Accepted
Date Advice Published: 9 June 2008

Back